EXETER — A leading expert in the treatment of hepatitis C said Tuesday that he is getting closer to gaining approval to use a new experimental treatment in a clinical trial on the patients impacted by the hepatitis C outbreak at Exeter Hospital.
Sequenta, Inc. announced today that SWOG has selected Sequenta’s LymphoSIGHT™ platform for the measurement of Minimal Residual Disease in a clinical trial.
A dying 12-year-old boy in Guangzhou recently donated his organs to help others, a sign of the country’s progress in setting up a transparent and effective system of organ donation, experts said.
A dying 12-year-old boy in Guangzhou recently donated his organs to help others, a sign of the country¡¯s progress in setting up a transparent and effective system of organ donation, experts said.
BACKGROUND: There are more than 1,600 people waiting for a lung transplant today. The wait for suitable donor organs to become available may be a year or longer. The average waiting time on the list is 18 months. Unfortunately, many patients who woul…
Miami scientists announced they have received federal approval to go forward with human trials aimed to find a cure for paralysis
SAN DIEGO — Vical Incorporated today reported financial results for the three months and six months ended June 30, 2012. Revenues were $1.6 million for the second quarter of 2012 compared with $0.8 million …
The Miami Project to Cure Paralysis, a Center of Excellence at the University of Miami Miller School of Medicine, has received permission from the Food and Drug Administration to begin a revolutionary Phase 1 clinical trial to evaluate the safety of tr…
MIAMI, July 31, 2012 /PRNewswire/ — The Miami Project to Cure Paralysis, a Center of Excellence at the University of Miami Miller School of Medicine, has received permission from the Food and Drug Administration …
Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, today announced treatment of the final patient in the first patient cohort in its Phase 1/2 clinical trial for Stargardt’s macular dystrophy using retinal pigment epithe…